The global Lexapro market is projected to witness steady growth through 2034, driven by the rising prevalence of depression and anxiety disorders, increasing mental health awareness, and expanding access to psychiatric treatments worldwide. The market continues to benefit from the growing adoption of long-term antidepressant therapy, improved diagnosis rates, and expanding healthcare...